Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for severe adult burn injury with >30% total body surface area
ACTRN12611000550909Phase 3Not yet recruiting
- Sponsor
- Burns, Trauma & Critical Care Research Centre
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of propranolol in burn injury (2 arms), sponsored by Burns, Trauma & Critical Care Research Centre. Primary endpoint: Body composition at 3 months. Planned start Jun 2011; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
burn injury
Beyond the preview
Go deeper on ACTRN12611000550909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000550909.